Literature DB >> 12464248

Analysis of homotropic and heterotropic cooperativity of diazepam oxidation by CYP3A4 using site-directed mutagenesis and kinetic modeling.

You Ai He1, Fabienne Roussel, James R Halpert.   

Abstract

The structural basis for the cooperativity of diazepam oxidation catalyzed by human cytochrome P450 3A4 (CYP3A4) and 40 mutants has been investigated. An ordered two-site model in which substrates bind first to a catalytic/effector site and then to the catalytic site was used to explain sigmoidal kinetics for temazepam formation but hyperbolic kinetics for nordiazepam formation. In this model diazepam binds to the enzyme-substrate complex with a greater affinity (K(S2)=140 microM) than to free enzyme (K(S1)=960 microM). Residues 107, 119, 211, 301, 304, 309, 369, 370, and 373 play an important role in determining regioselectivity of diazepam oxidation. Interestingly, S119F and A370F displayed sigmoidal kinetics for nordiazepam formation, whereas I301F exhibited hyperbolic kinetics for both products. In the presence of increasing concentrations of testosterone, K(S1) for diazepam decreased, whereas K(S2) increased. The data suggest that three sites exist within the active pocket.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12464248     DOI: 10.1016/s0003-9861(02)00484-8

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  22 in total

Review 1.  Allosteric P450 mechanisms: multiple binding sites, multiple conformers or both?

Authors:  Dmitri R Davydov; James R Halpert
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-12       Impact factor: 4.481

Review 2.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

3.  Spectral resolution of a second binding site for Nile Red on cytochrome P4503A4.

Authors:  Abhinav Nath; Cristina Fernández; Jed N Lampe; William M Atkins
Journal:  Arch Biochem Biophys       Date:  2008-03-25       Impact factor: 4.013

4.  Mechanism of interactions of alpha-naphthoflavone with cytochrome P450 3A4 explored with an engineered enzyme bearing a fluorescent probe.

Authors:  Tamara N Tsalkova; Nadezhda Y Davydova; James R Halpert; Dmitri R Davydov
Journal:  Biochemistry       Date:  2007-01-09       Impact factor: 3.162

5.  Resolution of two substrate-binding sites in an engineered cytochrome P450eryF bearing a fluorescent probe.

Authors:  Dmitri R Davydov; Alexandra E Botchkareva; Nadezhda E Davydova; James R Halpert
Journal:  Biophys J       Date:  2005-04-15       Impact factor: 4.033

6.  Resolution of multiple substrate binding sites in cytochrome P450 3A4: the stoichiometry of the enzyme-substrate complexes probed by FRET and Job's titration.

Authors:  Harshica Fernando; James R Halpert; Dmitri R Davydov
Journal:  Biochemistry       Date:  2006-04-04       Impact factor: 3.162

Review 7.  Understanding the mechanism of cytochrome P450 3A4: recent advances and remaining problems.

Authors:  Irina F Sevrioukova; Thomas L Poulos
Journal:  Dalton Trans       Date:  2012-09-27       Impact factor: 4.390

8.  Ligand diversity of human and chimpanzee CYP3A4: activation of human CYP3A4 by lithocholic acid results from positive selection.

Authors:  Santosh Kumar; Huan Qiu; Numan Oezguen; Holger Herlyn; James R Halpert; Leszek Wojnowski
Journal:  Drug Metab Dispos       Date:  2009-03-19       Impact factor: 3.922

9.  Effect of glutathione on homo- and heterotropic cooperativity in cytochrome P450 3A4.

Authors:  Dmitri R Davydov; Nadezhda Y Davydova; Tamara N Tsalkova; James R Halpert
Journal:  Arch Biochem Biophys       Date:  2008-01-11       Impact factor: 4.013

10.  QM/MM study of the active species of the human cytochrome P450 3A4, and the influence thereof of the multiple substrate binding.

Authors:  Dan Fishelovitch; Carina Hazan; Hajime Hirao; Haim J Wolfson; Ruth Nussinov; Sason Shaik
Journal:  J Phys Chem B       Date:  2007-11-17       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.